Pathway analysis suggests that miR-217 could be a potential oncogenic miRNA that negatively regulates the SIRT1, SMAD7, ROBO1, and FOXO3 genes, which are involved in tumor progression by diverse mechanisms (Figure 6). The gene discussed is SMAD7; the disease is neoplasm.